Unusual 11 Mid-Day Movers 05/26: CJBK, MELA, HAFC, NBIX, RODM, DY Up; GTXI, AEO, DJSP, BPHX, USU Down
Unusual 11 Mid-Day Movers :
Central Jersey Bancorp (NASDAQ: CJBK) 125.7% HIGHER; Kearny Financial Corp. (NASDAQ: KRNY) and Central Jersey jointly announced the execution of a definitive merger agreement which provides for the acquisition of Central Jersey by Kearny in an all cash transaction valued at $7.50 per share and an aggregate deal value of approximately $72.3 million.
GTx, Inc. (Nasdaq: GTXI) 31.8% LOWER; today announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate. Click here for the full report.
MELA Sciences, Inc. (Nasdaq: MELA) 25.3% HIGHER; announced today that the company's pre-market approval application for MelaFind will be reviewed by the General and Plastic Surgery Devices Panel appointed by the U.S. FDA on August 26, 2010. Click here to see the full report. The stock was also upgraded at Roth Capital.
Hanmi Financial Corporation (Nasdaq: HAFC) 24.6% HIGHER; today reported that it has entered into a securities purchase agreement with Woori Finance Holdings Co. Ltd. for an investment by Woori in Hanmi of up to $240 million. Click here to see the full report.
Neurocrine Biosciences Inc. (Nasdaq: NBIX) 23.5% HIGHER; still rallying up on news yesterday that statistically significant and clinically meaningful top-line efficacy results from its Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone receptor antagonist, elagolix, in patients with endometriosis. Shares of the company closed up 24.5% yesterday.
Rodman & Renshaw (Nasdaq: RODM) 16.8% HIGHER; may buyback up to $5 million worth of its common stock.
Dycom (NYSE: DY) 16.6% HIGHER; reports Q3 adj-EPS of $0.00, inline with the analyst estimate of $0.00. Revenue for the quarter was $231.6 million, which compares to the estimate of $227.16 million.
American Eagle (NYSE: AEO) 15.5% LOWER; reports Q1 EPS of $0.17, ex-items, inline with the analyst estimate of $0.17. Revenue for the quarter was $659.5 million, which compares to the estimate of $654.52 million. Sees Q2 adj-EPS of $0.12-$0.16, versus the consensus of $0.21.
DJSP Enterprises, Inc. (Nasdaq: DJSP) 9.5% LOWER; the company provides "non-legal services supporting residential real estate foreclosure, other related legal actions, and lender owned real estate (REO) services in the United States." Considering this, the superior new home sales number for April is not an indicator of a good business environment for DJSP.
Blue Phoenix (Nasdaq: BPHX) 8.0% LOWER; reports Q1 adjusted EPS of $0.01, versus the analyst estimate of $0.05. Revenue for the quarter was $17.3 million, which compares to the estimate of $18.46 million.
USEC Inc. (NYSE: USU) 7.2% LOWER; pulling back today after an unusual move upward on news that nuclear industry leaders Toshiba Corporation and Babcock & Wilcox Investment Company signed a definitive agreement to make an investment in USEC over three phases, each of which is subject to satisfaction of specific preconditions, including regulatory approvals. The $200 million investment, shared equally between Toshiba and B&W, will strengthen the deployment of the American Centrifuge Plant and create key new business opportunities throughout the nuclear fuel cycle. Shares of the company closed up 24% yesterday.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers..
Central Jersey Bancorp (NASDAQ: CJBK) 125.7% HIGHER; Kearny Financial Corp. (NASDAQ: KRNY) and Central Jersey jointly announced the execution of a definitive merger agreement which provides for the acquisition of Central Jersey by Kearny in an all cash transaction valued at $7.50 per share and an aggregate deal value of approximately $72.3 million.
GTx, Inc. (Nasdaq: GTXI) 31.8% LOWER; today announced top line results of the Phase III clinical trial evaluating toremifene 20 mg, a selective estrogen receptor modulator, for the prevention of prostate cancer in men with high grade prostatic intraepithelial neoplasia, or PIN, a premalignant lesion of the prostate. Click here for the full report.
MELA Sciences, Inc. (Nasdaq: MELA) 25.3% HIGHER; announced today that the company's pre-market approval application for MelaFind will be reviewed by the General and Plastic Surgery Devices Panel appointed by the U.S. FDA on August 26, 2010. Click here to see the full report. The stock was also upgraded at Roth Capital.
Hanmi Financial Corporation (Nasdaq: HAFC) 24.6% HIGHER; today reported that it has entered into a securities purchase agreement with Woori Finance Holdings Co. Ltd. for an investment by Woori in Hanmi of up to $240 million. Click here to see the full report.
Neurocrine Biosciences Inc. (Nasdaq: NBIX) 23.5% HIGHER; still rallying up on news yesterday that statistically significant and clinically meaningful top-line efficacy results from its Phase II Daisy PETAL study (901 study) using its proprietary, orally-active nonpeptide Gonadotropin-Releasing Hormone receptor antagonist, elagolix, in patients with endometriosis. Shares of the company closed up 24.5% yesterday.
Rodman & Renshaw (Nasdaq: RODM) 16.8% HIGHER; may buyback up to $5 million worth of its common stock.
Dycom (NYSE: DY) 16.6% HIGHER; reports Q3 adj-EPS of $0.00, inline with the analyst estimate of $0.00. Revenue for the quarter was $231.6 million, which compares to the estimate of $227.16 million.
American Eagle (NYSE: AEO) 15.5% LOWER; reports Q1 EPS of $0.17, ex-items, inline with the analyst estimate of $0.17. Revenue for the quarter was $659.5 million, which compares to the estimate of $654.52 million. Sees Q2 adj-EPS of $0.12-$0.16, versus the consensus of $0.21.
DJSP Enterprises, Inc. (Nasdaq: DJSP) 9.5% LOWER; the company provides "non-legal services supporting residential real estate foreclosure, other related legal actions, and lender owned real estate (REO) services in the United States." Considering this, the superior new home sales number for April is not an indicator of a good business environment for DJSP.
Blue Phoenix (Nasdaq: BPHX) 8.0% LOWER; reports Q1 adjusted EPS of $0.01, versus the analyst estimate of $0.05. Revenue for the quarter was $17.3 million, which compares to the estimate of $18.46 million.
USEC Inc. (NYSE: USU) 7.2% LOWER; pulling back today after an unusual move upward on news that nuclear industry leaders Toshiba Corporation and Babcock & Wilcox Investment Company signed a definitive agreement to make an investment in USEC over three phases, each of which is subject to satisfaction of specific preconditions, including regulatory approvals. The $200 million investment, shared equally between Toshiba and B&W, will strengthen the deployment of the American Centrifuge Plant and create key new business opportunities throughout the nuclear fuel cycle. Shares of the company closed up 24% yesterday.
To get this report daily visit http://www.streetinsider.com/entities/Unusual+11+Mid-Day+Movers..
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
New Home Sales, Roth Capital, Rodman & Renshaw, Unusual 11 Mid-Day Movers, Life, Style and Real EstateSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
